Researchers have developed DEERS, an interpretable deep learning recommender system designed to predict the effectiveness of kinase inhibitors across various cancer cell lines. By utilizing autoencoders to compress high-dimensional molecular features and drug inhibition profiles into low-dimensional representations, the model achieves state-of-the-art accuracy in forecasting drug sensitivity. Unlike traditional "black-box" neural networks, this system provides a novel interpretability framework that maps hidden dimensions to specific biological processes, such as DNA replication and MAPK signaling. Detailed case studies on drugs like Dabrafenib demonstrate how the model identifies the specific genetic drivers and cellular mechanisms responsible for a drug’s efficacy. Ultimately, this multi-task learning approach offers a powerful tool for personalized medicine by helping clinicians match the most effective therapies to individual patients based on their unique tumor profiles.
References:
Koras K, Kizling E, Juraeva D, et al. Interpretable deep recommender system model for prediction of kinase inhibitor efficacy across cancer cell lines[J]. Scientific reports, 2021, 11(1): 15993.

